MoU signed with CSPC Holdings Company Limited

26 July 2023

Pharmaniaga Berhad and Pharmaceutical Group Limited (CSPC) of China today forged a partnership on the research and development, manufacturing, and commercialisation of innovative pharmaceutical and biopharmaceutical products. The collaboration was sealed via a Memorandum of Understanding (MoU) signed by Pharmaniaga LifeScience Sdn Bhd (PLS) and CSPC Holdings Company Limited that underscores the mutual dedication of both parties to enhance the production of CSPC’s biopharmaceutical portfolio, focusing on its advanced mRNA vaccines, leading towards the commercialisation of these products in Malaysia and other relevant territories. The MoU was signed by Pharmaniaga Executive Committee (EXCO) Chairman; En. Ahmad Shahredzuan Mohd Shariff and CSPC Chairman; Mr. Cai Dongchen and witnessed by Member of Parliament for Bandar Kuching cum Special advisor to Minister of Health; YB Dr Kelvin Yii Lee Wuen, Malaysian Investment Development Authority (MIDA) Chief Executive Officer; Datuk Wira Arham Abdul Rahman and Ministry of Science, Technology and Innovation (MOSTI) Cluster Head of Malaysia Vaccine Project Office; Encik Mohd Hazwan Md Ghazali.